Refractory, locally advanced Non-small cell lung cancer

Also known as: Refractory, locally advanced Non small cell lung cancer

DrugDrug NameDrug Description
DB09063CeritinibAn antineoplastic kinase inhibitor used to treat anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) in patients with inadequate clinical response or intolerance to crizotinib.
DB01248DocetaxelA taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer.
DrugDrug NamePhaseStatusCount